Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedCore study details appear unchanged. The visible updates seem to be routine metadata like the study location list and the update timestamp.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedIntroducing a government-funded status notice and a version upgrade to v3.2.0, replacing v3.0.2.SummaryDifference3%

- Check43 days agoChange DetectedCore content removing MedlinePlus drug safety topics and related MeSH terms; overall narrowing of drug-safety coverage.SummaryDifference0.7%

- Check50 days agoChange DetectedMinor formatting/localization update: adds a Mexican spelling/locale variant (México, Mexico, 03100) and removes the generic variant (Mexico, Mexico, 03100) and the Back to Top link.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision updated from v3.0.0-post.1-g752effb-HEAD to v3.0.2 and a Back to Top link was added. The old revision tag was removed and there are no changes to core content, pricing, stock, or names.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page has updated the spelling of the location from 'México' to 'Mexico' and has changed the version number from 'v3.0.0' to 'v3.0.0-post.1-g752effb-HEAD'.SummaryDifference0.1%

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.